Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SALVENT STERULES | 0.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19114 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Resolved | 2017-03-12 | 2017-05-10 | 689 |
| APO-SALVENT-IPRAVENT STERULES | 0.5MG 2.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19323 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2022-02-04 | 2022-07-11 | 154208 |
| APO-SAXAGLIPTIN | 2.5MG | TABLET | Resolved | 2022-01-14 | 2022-07-19 | 152773 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2021-12-10 | 2022-01-31 | 150896 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2024-10-24 | 2025-01-03 | 241063 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-17 | 2024-01-12 | 210683 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-11-28 | 2018-02-23 | 30963 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-05-24 | 2024-07-05 | 228786 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-07-16 | 2018-08-31 | 55847 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2020-04-15 | 2020-05-11 | 112195 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-27 | 2024-04-12 | 223540 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-11-10 | 2024-01-19 | 209945 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2021-10-01 | 2021-12-06 | 146514 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2024-08-09 | 2024-09-06 | 234992 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-11-28 | 2018-01-18 | 30967 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-11-09 | 2018-01-31 | 28709 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-06-13 | 2017-10-12 | 12698 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2018-02-21 | 2018-06-12 | 40377 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |